NDC 11523-7202-01 - Claritin Reditabs
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11523-7202
- Requested NDC
- 11523-7202-01
- Package NDCs from labels
- 11523-7202-1, 11523-7202-3, 11523-7202-01
- Manufacturer
- Bayer HealthCare LLC
- Effective date
- 2025-12-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Claritin Reditabs - Bayer HealthCare LLC | Bayer HealthCare LLC | 2025-12-05 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11523-7202-1 | ClaritinReditabs | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | 12 | |
| 11523-7202-1 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7202-3 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7202-3 | ClaritinReditabs | 1 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 1 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11523-7202 | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [BAYER HEALTHCARE LLC] | 11 | Current NDC, Legacy NDC, 4 package rows | 20241208_7dc04b48-f053-4e4b-a493-9e8286d2a791.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 11523-7202-1 | EA - Each | 11523-7202 | 2d9569c3-1d2b-4a96-a48f-54e4ce505bd9 | 1 | 2012-07-24 |
| 11523-7202-3 | EA - Each | 11523-7202 | 8c62db1c-bc79-4bd8-aae5-46837fb33bf9 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Loratadine | ACTIVE INGREDIENT | 7AJO3BO7QN | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| Loratadine | ACTIVE MOIETY | 7AJO3BO7QN | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| gelatin | INACTIVE INGREDIENT | 2G86QN327L | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | CLARITIN REDITABS (LORATADINE) TABLET, ORALLY DISINTEGRATING [MSD CONSUMER CARE, INC.] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| allergy relief | LORATADINE | CVS Pharmacy | 0038bc38-c205-4d8d-ab78-1abbcd76829e | 2026-02-25 | Warnings | 7AJO3BO7QN |
| allergy relief | LORATADINE | Kroger Company | 745d48f2-504d-4e3d-abf8-768d201cf814 | 2026-02-24 | Warnings | 7AJO3BO7QN |
| Alavert Allergy | LORATADINE | Foundation Consumer Brands | f741d1cf-0ecb-4405-8596-07af394537db | 2026-02-23 | Warnings | 7AJO3BO7QN |
| Loratadine Allergy Relief | LORATADINE | A-S Medication Solutions | a53e5635-8633-4c28-b04f-cdfb3d851e68 | 2026-02-19 | Warnings | 7AJO3BO7QN |
| Mitochondria Pro | ARALIA QUINQUEFOLIA, ARNICA MONTANA, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, ASCORBICUM ACIDUM, ALPHA-LIPOICUM ACIDUM, CALCAREA CARBONICA, CITRICUM ACIDUM, CUPRUM METALLICUM, CYSTEINUM, FERRUM METALLICUM, IODIUM, LEVOTHYROXINUM, MAGNESIUM GLUCONICUM DIHYDRICUM, MALICUM ACIDUM, MANGANUM ACETICUM, NADIDUM, NATRUM PYRUVICUM, NICOTINAMIDUM, PYRIDOXINUM HYDROCHLORICUM, RIBOFLAVINUM, SELENIUM METALLICUM, SULPHUR, THIAMINUM HYDROCHLORICUM, UBIDECARENONUM, ZINCUM METALLICUM, | Energique, Inc. | 2f365207-b730-428d-9465-8853e86e79ff | 2026-02-18 | Warnings | XF417D3PSL |
| Berkley and Jensen Allergy Relief | LORATADINE | BJWC | e981a0ef-08e9-4ac3-92a1-411217e0a251 | 2026-02-16 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | Major Pharmaceuticals | 60162446-4fa1-4ee3-ae20-19fadc2491ab | 2026-02-09 | Warnings | 7AJO3BO7QN |
| Loratadine and Pseudoephedrine | LORATADINE AND PSEUDOEPHEDRINE | Sportpharm LLC | 2b432b67-f9f3-45e2-8306-2d4080152f99 | 2026-02-06 | Warnings | 7AJO3BO7QN |
| loratadine D | LORATADINE, PSEUDOEPHEDRINE SULFATE | Sportpharm LLC | bb54f613-b2ab-48fd-83c9-2038ec7097f6 | 2026-02-06 | Warnings | 7AJO3BO7QN |
| Childrens Loratadine Oral | LORATADINE | Atlantic Biologicals | 4a1a6981-133c-d45b-e063-6294a90a4a09 | 2026-02-05 | Warnings | 7AJO3BO7QN |
| Allergy Relief | LORATADINE | Kroger Company | dac0b200-6b02-4c8a-b1dd-a4d5341dfb2d | 2026-02-05 | Warnings | 7AJO3BO7QN |
| Loratadine | LORATADINE | Strategic Sourcing Services, LLC | a527f83a-4ae9-47b1-94e0-7ab3148b025f | 2026-01-29 | Warnings | 7AJO3BO7QN |
| Allergy Relief | LORATADINE | HyVee Inc | b6ee2b7f-8e01-4962-b28f-91e5cac85276 | 2026-01-28 | Warnings | 7AJO3BO7QN |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Atlantic Biologicals Corp. | 42d837ae-2578-46df-92d2-24774964aaad | 2026-01-28 | Adverse reactions | XF417D3PSL |
| Childrens Loratadine Sugar Free | LORATADINE | Preferred Pharmaceuticals Inc. | 23936948-71bf-4c18-9160-22b7075e675d | 2026-01-15 | Warnings | 7AJO3BO7QN |
| Childrens Loratadine Sugar Free | LORATADINE | Walgreen Company | 42a73448-104a-4c7f-aea0-cef44d15f5f1 | 2026-01-13 | Warnings | 7AJO3BO7QN |
| Cell Energy Performance Drops 2048 | CELL ENERGY PERFORMANCE DROPS | Professional Complementary Health Formulas | 8701ea61-5d5f-466b-8d2c-f808e7b4d8fe | 2026-01-08 | Warnings | XF417D3PSL |
| Metab 6012 | METAB | Professional Complementary Health Formulas | f3576d6f-c9ab-4370-8a32-b6c4bf6ba4fd | 2026-01-08 | Warnings | XF417D3PSL |
| Herbal Diuretic Liquescence 3011 | HERBAL DIURETIC LIQUESCENCE | Professional Complementary Health Formulas | 5eee7f21-a3c4-46e0-a642-a4ca635734e3 | 2026-01-08 | Warnings | XF417D3PSL |
| LORATADINE | LORATADINE | Advagen Pharma Limited | a5699a95-c0a7-43ea-9bab-bbfaba3c8aa5 | 2026-01-05 | 7AJO3BO7QN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.